10-Year Lung Cancer-Specific Survival for Low-Dose CT Persists

TUESDAY, Dec. 5, 2023 -- For an expanded International-Early Lung Cancer Action Program (I-ELCAP) cohort who underwent annual low-dose computed tomography (CT) screening, the 10-year lung cancer-specific survival of 80 percent reported in 2006 has...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news